iRhythm Technologies, Inc. (NASDAQ:IRTC – Get Rating) Director Merz Cathleen Noel Bairey sold 500 shares of the business’s stock in a transaction dated Tuesday, June 14th. The stock was sold at an average price of $111.76, for a total transaction of $55,880.00. Following the sale, the director now owns 4,977 shares in the company, valued at $556,229.52. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
Shares of IRTC stock traded down $8.90 during mid-day trading on Thursday, reaching $106.36. The company’s stock had a trading volume of 15,387 shares, compared to its average volume of 381,052. iRhythm Technologies, Inc. has a 1-year low of $41.66 and a 1-year high of $169.54. The company has a market cap of $3.17 billion, a P/E ratio of -24.57 and a beta of 1.23. The company has a debt-to-equity ratio of 0.14, a quick ratio of 4.43 and a current ratio of 4.63. The firm’s 50-day moving average is $134.82 and its two-hundred day moving average is $127.69.
iRhythm Technologies (NASDAQ:IRTC – Get Rating) last announced its quarterly earnings data on Thursday, May 5th. The company reported ($0.80) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.06) by $0.26. iRhythm Technologies had a negative net margin of 36.43% and a negative return on equity of 34.55%. The company had revenue of $92.40 million during the quarter, compared to analysts’ expectations of $86.76 million. During the same quarter in the prior year, the company posted ($0.95) EPS. The business’s revenue was up 24.4% on a year-over-year basis. Sell-side analysts anticipate that iRhythm Technologies, Inc. will post -3.28 EPS for the current year.
Several hedge funds and other institutional investors have recently modified their holdings of IRTC. Vanguard Group Inc. raised its position in shares of iRhythm Technologies by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 2,714,221 shares of the company’s stock valued at $427,409,000 after acquiring an additional 33,521 shares during the period. BlackRock Inc. raised its holdings in iRhythm Technologies by 0.4% during the 1st quarter. BlackRock Inc. now owns 2,093,147 shares of the company’s stock worth $329,607,000 after buying an additional 8,440 shares during the period. JPMorgan Chase & Co. raised its holdings in iRhythm Technologies by 16.1% during the 4th quarter. JPMorgan Chase & Co. now owns 2,079,429 shares of the company’s stock worth $244,728,000 after buying an additional 287,654 shares during the period. Capital Research Global Investors raised its holdings in iRhythm Technologies by 60.9% during the 1st quarter. Capital Research Global Investors now owns 1,411,300 shares of the company’s stock worth $222,237,000 after buying an additional 534,300 shares during the period. Finally, Wellington Management Group LLP raised its holdings in iRhythm Technologies by 1.9% during the 3rd quarter. Wellington Management Group LLP now owns 1,114,699 shares of the company’s stock worth $65,277,000 after buying an additional 20,364 shares during the period. 97.92% of the stock is currently owned by institutional investors.
iRhythm Technologies Company Profile (Get Rating)
iRhythm Technologies, Inc, a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias.
- Get a free copy of the StockNews.com research report on iRhythm Technologies (IRTC)
- The Q2 Earnings Season Could Be A Bloodbath
- Commercial Metals Company Is Ready To Rebound
- The Institutions Turn The Tide For Jabil
- A10 Networks: Key 5G Infrastructure Stock that’s Beating the Market
- Allstate: A Safe Stock During Volatile Times, Which Will Benefit From Rising Rates
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for iRhythm Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iRhythm Technologies and related companies with MarketBeat.com's FREE daily email newsletter.